# Understanding the Complexity of Early-Onset Dementia

**Authors:** Nicole Ann E Villa, Charles Wen, Eduardo D Espiridion

PMC · DOI: 10.7759/cureus.57897 · Cureus · 2024-04-09

## TL;DR

This paper discusses the challenges of diagnosing early-onset dementia and highlights the importance of thorough evaluations for accurate diagnosis and treatment.

## Contribution

The paper emphasizes the need for comprehensive assessments in diagnosing early-onset dementia to avoid misdiagnosis and improve patient outcomes.

## Key findings

- Early-onset dementia is challenging to diagnose and often leads to delays or errors.
- A thorough history and physical examination are crucial for identifying potential reversible causes of cognitive decline.
- Timely multidisciplinary treatment is essential for chronic neurocognitive disorders like Alzheimer’s disease.

## Abstract

Dementia, particularly Alzheimer’s disease, affects millions globally, with its prevalence increasing notably with age. Early-onset Alzheimer’s disease, however, affects individuals under 65 years old. Unfortunately, diagnosing dementia in patients under 65 years old is quite challenging and is often delayed, missed, or wrong. Thus, we present the case of a 60-year-old female, with a medical history of hypothyroidism and presumed dementia on donepezil, who presented to the emergency department for agitation, dramatic change in personality and behavior, as well as cognitive decline that started in her late 50s. We discuss the importance of performing a thorough history and physical examination, as well as a comprehensive workup for patients who present with dramatic changes in behavior due to the wide range of potential diagnoses. While certain reversible causes, such as hypothyroidism, nutritional deficiencies, and polypharmacy, can be promptly identified and treated, chronic neurocognitive disorders such as Alzheimer’s disease demand a timely evaluation for early multidisciplinary treatment to enhance patient outcomes.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975), hypothyroidism (MONDO:0005420)

## Full-text entities

- **Diseases:** Alzheimer's disease (MESH:D000544), agitation (MESH:D011595), neurocognitive disorders (MESH:D019965), cognitive decline (MESH:D003072), hypothyroidism (MESH:D007037), Dementia (MESH:D003704), nutritional deficiencies (MESH:D044342)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11080675/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11080675/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC11080675/full.md

---
Source: https://tomesphere.com/paper/PMC11080675